Vous recherchez un emploi hautement qualifié en Valais ?
Vous recherchez du personnel hautement qualifié (Université, EPF, HES, ES, brevet, etc.) pour votre entreprise en Valais ?
VSlink regroupe:
- 738 entreprises
- 6449 candidats hautement qualifiés
Vous recherchez du personnel hautement qualifié (Université, EPF, HES, ES, brevet, etc.) pour votre entreprise en Valais ?
VSlink regroupe:
- 738 entreprises
- 6449 candidats hautement qualifiés
Vous êtes ici > Bourse des emplois > QA Group Leader Cell Banking & Microbial Control Strategy (m/f/d) - R40020
![](/template/image/imageT4.jpg)
![](/data/images/logo/3277865e714cc11f162e4dedd655e706.jpg)
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B3 compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 full-time employees worldwide. The company generated sales of CHF 3.8 billion in 2015 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
QA Group Leader Cell Banking & Microbial Control Strategy (m/f/d) - R40020
Document lié | ![]() |
Plus d'infos | ![]() |
Validité de l'offre | 31.01.2022 |
No référence | 110709 |
Contact
Pour avoir accès à cette information vous devez être inscrit à VSlink